Does correction of the friedewald formula using lipoprotein(a) change our estimation of ischemic heart disease risk? The Quebec Cardiovascular Study
- 1 August 2002
- journal article
- clinical trial
- Published by Elsevier in Atherosclerosis
- Vol. 163 (2) , 261-267
- https://doi.org/10.1016/s0021-9150(02)00034-5
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Predictors of plasma lipoprotein(a) concentration in the West of Scotland Coronary Prevention Study cohortAtherosclerosis, 1999
- Apolipoprotein(a) isoforms and coronary heart disease in men: A nested case-control studyAtherosclerosis, 1997
- Apolipoprotein(a) Kringle IV Repeat Number Predicts Risk for Coronary Heart DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 1996
- Effects of the apolipoprotein(a) size polymorphism on the lipoprotein(a) concentration in 7 ethnic groupsHuman Genetics, 1991
- Lp(a) levels in different types of dyslipidemia in the French populationAtherosclerosis, 1990
- Incidence of Lp(a) Lipoprotein among PopulationsPublished by Elsevier ,1990
- Plasma Ip(a) concentration is inversely correlated with the ratio of Kringle IV/Kringle V encoding domains in the apo(a) gene.Journal of Clinical Investigation, 1989
- Increase in plasma high-density lipoprotein concentration following complete androgen blockage in men with prostatic carcinomaMetabolism, 1987
- Sur un dosage rapide du cholesterol lié aux α-et aux β-lipoprotéines du sérumClinica Chimica Acta; International Journal of Clinical Chemistry, 1960
- THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUMJournal of Clinical Investigation, 1955